X4 Pharmaceuticals, Inc
Nasdaq · Healthcare · Biological Products, (No Diagnostic Substances) · Boston, MA
XFOR chart
What traders are saying about $XFOR
Latest postsX4 Pharmaceuticals, Inc news
- X4 Pharmaceuticals, Inc. (XFOR) Seasonal returns chart
Yahoo Finance UK ·
- X4 Pharmaceuticals, Inc. (NASDAQ:XFOR) Released Earnings Last Week And Analysts Lifted Their Price Target To US$11.60
Simply Wall St ·
- X4 Pharmaceuticals (XFOR) Institutional Ownership 2026 $XFOR
MarketBeat ·
- Leerink Partners Maintains X4 Pharmaceuticals(XFOR.US) With Buy Rating, Maintains Target Price $12
Moomoo ·
- Can X4 Pharmaceuticals(NASDAQ:XFOR) Transform Chronic Neutropenia Treatment with Its 4WARD and 4STEPS Trials?
Kalkine ·
- X4 PHARMACEUTICALS Q3 OPERATING EXPENSES USD 22.87 MILLION
Moomoo ·
- X4 Pharmaceuticals reports Q3 EPS (16c), consensus (19c)
TipRanks ·
- X4 Pharmaceuticals, Inc. reports results for the quarter ended September 30 - Earnings Summary
TradingView ·
- X4 Pharmaceuticals (XFOR) Reports Q3 Loss, Tops Revenue Estimates
Yahoo Finance ·
- X4 Pharmaceuticals: Q3 Earnings Snapshot
Yahoo Finance ·
- X4 Pharmaceuticals Q3 revenue rises on XOLREMDI sales
TradingView ·
- X4 Pharmaceuticals Reports Third Quarter 2026 Financial Results and Provides Corporate Update
Yahoo Finance ·
X4 Pharmaceuticals, Inc key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $35.1M | $2.6M | $0 | $0 |
| Net income | -$79.2M | -$37.5M | -$101.2M | -$93.9M |
| Diluted EPS | $-1.87 | $-5.59 | $-17.07 | $-1.52 |
| Total assets (year end) | $290.5M | $146.4M | $147.3M | $155.6M |
| Cash and equivalents (year end) | $217.0M | $55.7M | $99.2M | $121.7M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About X4 Pharmaceuticals, Inc
- Ticker
- XFOR (Nasdaq)
- Industry
- Biological Products, (No Diagnostic Substances)
- Headquarters
- Boston, MA
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1501697
- Former names
- Arsanis, Inc.
Frequently asked questions
What exchange is X4 Pharmaceuticals, Inc listed on?
X4 Pharmaceuticals, Inc trades on the Nasdaq under the ticker symbol XFOR.
What industry is X4 Pharmaceuticals, Inc in?
X4 Pharmaceuticals, Inc is classified by the SEC under "Biological Products, (No Diagnostic Substances)", part of the Healthcare sector on StockTweeting.
Where is X4 Pharmaceuticals, Inc headquartered?
X4 Pharmaceuticals, Inc's business address on file with the SEC is in Boston, MA.
When does X4 Pharmaceuticals, Inc's fiscal year end?
X4 Pharmaceuticals, Inc's fiscal year ends on December 31.
How much revenue did X4 Pharmaceuticals, Inc report?
X4 Pharmaceuticals, Inc reported $35.1M in revenue for calendar year 2025, according to its SEC filings.